Literature DB >> 9346436

Global forebrain ischemia results in differential cellular expression of interleukin-1beta (IL-1beta) and its receptor at mRNA and protein level.

T R Sairanen1, P J Lindsberg, M Brenner, A L Sirén.   

Abstract

The mRNA expression of the proinflammatory cytokine interleukin-1beta (IL-1beta) has been shown to be induced in neural elements during ischemia. It is not clear which cells generate the IL-1beta mRNA and eventually synthesize IL-1 protein and which cells respond to this signaling by producing IL-1 receptors during ischemia. To clarify this question, rats were subjected to global ischemia by bilateral carotid occlusion and hypotension for 20 minutes, followed by reperfusion for 2 hours (n = 7), 8 hours (n = 7), or 24 hours (n = 7). Cryostat sections were hybridized using antisense oligonucleotide probes (30 dimer). Multiple cell markers were used in immunohistochemical staining to identify the cells expressing IL-1beta and IL-1R protein. The sham animals (n = 5) showed no or only a weak expression of IL-1R or IL-1beta mRNA. The number of IL-1beta mRNA-expressing cells was significantly increased by 2 hours of reperfusion in several brain areas including cortex (12-fold compared with sham) and caudate-putamen (14-fold), and was maximally increased in most hippocampal regions by 8 hours of reperfusion (mean +/- SD of positive cells/field versus sham equivalent being 37.9 +/- 12.3 versus 4.0 +/- 3.3; 30.6 +/- 9.0 versus 3.1 +/- 2.3; 41.3 +/- 17.5 versus 2.9 +/- 1.9; in CA1; CA2; CA3/CA4 regions of the hippocampus, respectively). IL-1beta mRNA signal was also intensified in the white matter areas. Changes in IL-1R mRNA were seen in the hippocampus (after 2 hours CA1: 16-fold; CA2: 17-fold; DG: 24-fold increase; and CA3/CA4: 10-fold increase after 8 hours), and the expression was prolonged especially in CA1 and CA2 regions up to 24 hours of reperfusion. The major cellular source of IL-1beta protein was glia (astrocytes, oligodendrocytes, microglia, and scattered perivascular macrophages/monocytes), while neurons and sporadic microvascular endothelia showed IL-1R immunoreactivity. The data suggest that neurons in discrete areas vulnerable for selective neuronal death, and possibly the vascular endothelium, are target cells for ischemia-induced glial IL-1beta production.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9346436     DOI: 10.1097/00004647-199710000-00013

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  25 in total

1.  Differential glial and vascular expression of endothelins and their receptors in rat brain after neurotrauma.

Authors:  A L Sirén; F Knerlich; L Schilling; H Kamrowski-Kruck; A Hahn; H Ehrenreich
Journal:  Neurochem Res       Date:  2000-07       Impact factor: 3.996

2.  Corticotropin releasing factor-1 receptor antagonism alters the biochemical, but not behavioral effects of repeated interleukin-1β administration.

Authors:  Clare J Wilhelm; Aaron Murphy-Crews; Daniel J Menasco; Marilyn S Huckans; Jennifer M Loftis
Journal:  Neuropharmacology       Date:  2011-08-04       Impact factor: 5.250

3.  Cortical cell death induced by IL-1 is mediated via actions in the hypothalamus of the rat.

Authors:  S M Allan; L C Parker; B Collins; R Davies; G N Luheshi; N J Rothwell
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

4.  Regional TNFα mapping in the brain reveals the striatum as a neuroinflammatory target after ventricular fibrillation cardiac arrest in rats.

Authors:  Andreas Janata; Ingrid A M Magnet; Thomas Uray; Jason P Stezoski; Keri Janesko-Feldman; Samuel A Tisherman; Patrick M Kochanek; Tomas Drabek
Journal:  Resuscitation       Date:  2014-02-12       Impact factor: 5.262

5.  Role of IL-1alpha and IL-1beta in ischemic brain damage.

Authors:  H Boutin; R A LeFeuvre; R Horai; M Asano; Y Iwakura; N J Rothwell
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

Review 6.  Brain vulnerability and viability after ischaemia.

Authors:  Stefano G Daniele; Georg Trummer; Konstantin A Hossmann; Zvonimir Vrselja; Christoph Benk; Kevin T Gobeske; Domagoj Damjanovic; David Andrijevic; Jan-Steffen Pooth; David Dellal; Friedhelm Beyersdorf; Nenad Sestan
Journal:  Nat Rev Neurosci       Date:  2021-07-21       Impact factor: 34.870

Review 7.  The expanding interleukin-1 family and its receptors: do alternative IL-1 receptor/signaling pathways exist in the brain?

Authors:  Herve Boutin; Ian Kimber; Nancy J Rothwell; Emmanuel Pinteaux
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

8.  NMDA receptor antagonist MK-801 reduces neuronal damage and preserves learning and memory in a rat model of traumatic brain injury.

Authors:  Rui-Zhang Han; Jin-Jia Hu; Yuan-Chi Weng; Ding-Feng Li; Yi Huang
Journal:  Neurosci Bull       Date:  2009-12       Impact factor: 5.203

Review 9.  Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression.

Authors:  Ja Wook Koo; Ronald S Duman
Journal:  Curr Opin Investig Drugs       Date:  2009-07

10.  IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress.

Authors:  Ja Wook Koo; Ronald S Duman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.